News
AIG Announces Early Participation Results of Its Tender Offers and Extends the Total Consideration Payment and Certain Consent Solicitations
On May 11, 2021, American International Group, Inc. (NYSE: AIG) announced that it commenced cash tender offers (the “Tender Offers”) and solicitations of consents (the “Consent Solicitations”) for
![OneSpan Outlines Strength of Highly Qualified Board of Directors in Letter to Stockholders](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
OneSpan Outlines Strength of Highly Qualified Board of Directors in Letter to Stockholders
OneSpan Inc. (NASDAQ: OSPN), the global leader in securing remote banking transactions, today issued a letter to its stockholders outlining the strength of its highly qualified Board of Directors
![Cubic Enhances Ventra Card Offering to Include Contactless Fare Payment Option for Android Users](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Cubic Enhances Ventra Card Offering to Include Contactless Fare Payment Option for Android Users
Cubic Corporation (NYSE: CUB) today announced its Cubic Transportation Systems (CTS) business division, the Chicago Transit Authority (CTA) and Pace Suburban Bus (Pace) launched the virtual Ventra
![Born Digital Poised to Deliver Substantial Economic Gains – But They’ll Need Some Help: https://mms.businesswire.com/media/20191101005123/en/196157/5/Citrix_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN3dqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f68e2ea35e679548c2f8b4346a61ad32e7739bf0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Citrix_logo.jpg?locale=us)
Born Digital Poised to Deliver Substantial Economic Gains – But They’ll Need Some Help
Today’s young employees are the engines of the knowledge economy and tomorrow’s business leaders. And according to The Born Digital Effect, the latest research from Citrix Systems, Inc.
![Eros Now Outlines Detailed Operating Metrics for Fiscal Year 2021 and Updates Forward Guidance](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Eros Now Outlines Detailed Operating Metrics for Fiscal Year 2021 and Updates Forward Guidance
Eros Now, a leading over-the-top (OTT) South Asian entertainment platform owned by Eros STX Global Corporation (NYSE: ESGC) (“ErosSTX” or “the Company”), a global entertainment company, today
![UiPath Launches Third Annual UiPath Automation Awards to Spotlight Emerging Software Automation Companies: https://mms.businesswire.com/media/20210427005075/en/718791/5/new_uipath_logo_orange.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemR1Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--50f843081684f238e6dd1d51a03e004067551830/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/new_uipath_logo_orange.jpg?locale=us)
UiPath Launches Third Annual UiPath Automation Awards to Spotlight Emerging Software Automation Companies
UiPath (NYSE: PATH), a leading enterprise automation software company, today announced the launch of the UiPath Automation Awards 2021, its third annual competition designed to champion the most
![Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNElsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c4d0ef2109eb59269aca9850381b8fb5000d84e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Xencor_RGB_fullcolor.jpg?locale=us)
Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
![Lomiko Metals CEO Speaks on the Electric Vehicle Revolution at the Emerging Growth Conference on May 26, 2021](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Lomiko Metals CEO Speaks on the Electric Vehicle Revolution at the Emerging Growth Conference on May 26, 2021
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) invites individuals, institutional investors, advisors and analysts to attend its real-time, interactive
![Foresight: Eye-Net To Pursue Potential Nasdaq Listing](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Foresight: Eye-Net To Pursue Potential Nasdaq Listing
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd., intends to pursue a
![Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases
Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method
![ImmunoPrecise Names Dr. Dion Neame to Strategic Advisory Board: https://mms.businesswire.com/media/20210203005983/en/857090/5/ImmunoPrecise_logo_HZ_PMS.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeWtBVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--000b3982bf8e90eb30a01cca9649be03b0baae66/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ImmunoPrecise_logo_HZ_PMS.jpg?locale=us)
ImmunoPrecise Names Dr. Dion Neame to Strategic Advisory Board
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Dion Neame
![Tokens.com Purchases Additional Operating Assets: https://mms.businesswire.com/media/20210525005244/en/880744/5/tokens-logo_%281%29_%282%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK3lWVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b22e553b962915f764e42c73681e9e30bf76aa5c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/tokens-logo_-281-29_-282-29.jpg?locale=us)
Tokens.com Purchases Additional Operating Assets
Tokens.com Corp. (NEO:COIN) (FSE:76M) (“Tokens.com” or “the Company”) is a blockchain technology company that provides transaction processing and validation services for various digital assets that
![Artmarket.com: real paintings by blue-chip artists remain the super-stars of the art market, says Artprice](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Artmarket.com: real paintings by blue-chip artists remain the super-stars of the art market, says Artprice
The Art Market seemed to have forgotten its past and all of its reference points after the online sale of Beeple's NFT Everydays (which sold for $69 million at the beginning of March). But the major
![Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzJBRWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5cbb888b15fc1babe89717dad3b9d241825019eb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/novocure_main-405x.jpg?locale=us)
Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma
Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with GT Medical Technologies, Inc., to develop Tumor Treating Fields (TTFields) together with GT
![Large Latin American Financial Institution Moves 10,000 Agents to NICE CXone: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtvRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--06f22a0c3a8fabdec4f231cf3ebdea0279feec53/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NICE_inContact.jpg?locale=us)
Large Latin American Financial Institution Moves 10,000 Agents to NICE CXone
NICE CXone (Nasdaq: NICE) today announced one of the largest financial institutions in Latin America has chosen CXone, the industry’s most proven, complete and smart customer experience platform
American Express Executives to Participate in Upcoming Investor Conferences
American Express (NYSE: AXP) today announced its participation in upcoming investor conferences, which will be held virtually.
On Friday, June 4, 2021, Chairman and Chief Executive Officer
![NICE Launches Enlighten AI Routing, Innovating CX with Next-Gen Intelligence: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtvRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--06f22a0c3a8fabdec4f231cf3ebdea0279feec53/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NICE_inContact.jpg?locale=us)
NICE Launches Enlighten AI Routing, Innovating CX with Next-Gen Intelligence
NICE (Nasdaq: NICE) today announced the launch of NICE Enlighten AI Routing, enabling hyper-personalized, next-gen experiences in real-time. Powered by data from NICE Enlighten AI and infused with
![TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, announced today that the Company submitted a supplemental New Drug Application (“sNDA”) for BIJUVA (estradiol
![AdvanSix to Present at Stifel Virtual Cross Sector Insight Conference: https://mms.businesswire.com/media/20210330005438/en/868158/5/AdvanSix_Logo_Color_RGB.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXRLVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b5b08b00177a6ea96f7f3179af158059ad9af5a3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AdvanSix_Logo_Color_RGB.jpg?locale=us)
AdvanSix to Present at Stifel Virtual Cross Sector Insight Conference
AdvanSix (NYSE: ASIX) announced that Michael Preston, SVP and CFO of AdvanSix, will be presenting at the Stifel Virtual Cross Sector Insight Conference on Tuesday, June 8, 2021 from 2:40 – 3:10
![ICON plc to Present at the Jefferies Virtual Healthcare Conference and the William Blair 41st Growth Stock Conference: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMWRYRVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--91b049194ccf9261ff5ab4a8879b7c494da2dc48/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ICON_Positive_logo_PNG_-28nostrap-29.jpg?locale=us)
ICON plc to Present at the Jefferies Virtual Healthcare Conference and the William Blair 41st Growth Stock Conference
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
![Which Retailers Are Using Facial Recognition In Stores – Scorecard](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Which Retailers Are Using Facial Recognition In Stores – Scorecard
New Report and Scorecard Shows Which Retailers Are Using Facial Recognition on Shoppers, Employees
if (typeof jQuery == 'undefined') { document.write('<scr' + 'ipt![Inseego and Net4 Join Forces to Deliver 5G Solutions for Private Networks Across Europe](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Inseego and Net4 Join Forces to Deliver 5G Solutions for Private Networks Across Europe
Inseego Corp. (Nasdaq: INSG), a leader in 5G and IoT device-to-cloud solutions, today announced a collaboration with Net4, an expert systems integrator of IoT solutions, to drive and simplify the
![NOXXON Announces Convocation of Its Hybrid 2021 Annual General Meeting of Shareholders](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
NOXXON Announces Convocation of Its Hybrid 2021 Annual General Meeting of Shareholders
Regulatory News:
NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME)
![Eurofins Expands Its Global Sequencing and Mutation-Specific PCR Capabilities to Detect COVID-19 Variants of Concern and of Interest: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdzNhTUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--39aa1a81526ac2a70cd04ea71d1ab318c23b607c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/EUROFINS_.jpg?locale=us)
Eurofins Expands Its Global Sequencing and Mutation-Specific PCR Capabilities to Detect COVID-19 Variants of Concern and of Interest
As the number of types of COVID-19 Variants of Concern and of interest increases, fast high throughput NGS sequencing is key to identify new variants while mutation specific PCR testing enables
![Technip Energies Awarded Two Contracts by Neste for Development of Its Rotterdam Renewables Production Platform: https://mms.businesswire.com/media/20210325005821/en/867429/5/TECHNIP_ENERGIES_LOGO_HORIZONTAL_RVB.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTFHVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c93784afd984798abd396173ebfcd5dc86a60d73/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/TECHNIP_ENERGIES_LOGO_HORIZONTAL_RVB.jpg?locale=us)
Technip Energies Awarded Two Contracts by Neste for Development of Its Rotterdam Renewables Production Platform
Regulatory News:
Technip Energies (PARIS:TE) (ISIN:NL0014559478) has been awarded two contracts(1) by Neste for work on the development of their renewables production platform in Rotterdam, the